D-Aasma Tablets are available in both 400 mg and 200 mg formulations, containing the generic name Doxofylline.
Categorized as Antiasthmatic, Doxofylline in D-Aasma is effective in managing conditions like asthma and chronic obstructive pulmonary disease (COPD).
The Antiasthmatic action of Doxofylline involves improving airflow to the lungs and reducing airway inflammation.
D-Aasma offers flexibility in dosing with the availability of both 400 mg and 200 mg Tablets, catering to individual patient needs.
The active ingredient, Doxofylline, aims to enhance bronchodilation, providing relief from respiratory distress and promoting better respiratory function.
D-Aasma exemplifies a commitment to respiratory health by addressing symptoms at their core, contributing to an improved quality of life for individuals with respiratory disorders.
About Supplier
Asia Pharma Link committed to bridging healthcare gaps and plays a vital role in distributing medical and surgical items to various locations across Nepal. With a focus on ensuring widespread access to quality healthcare, the company serves as a crucial link in the pharmaceutical supply chain. Whether catering to healthcare professionals or meeting the needs of consumers, Asia Pharma Link takes pride in its role as a reliable source of essential medicines. With a broad distribution network, the company extends its reach to different regions of Nepal, contributing significantly to the nation's healthcare landscape.
D-Aasma 200mg/ 400mg Tablets
Wholesale Information
Minimum Order Quantity: 10 Unit
Ask for latest price & discounts
Please contact the supplier for any information you need about the product.
